| Particulars (Rupees in Crores.) | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 | 
|---|---|---|---|---|---|
Gross Sales  | 1,569.4  | 1,465.7  | 1,239.69  | 1,258.51  | 1,138.09  | 
Excise Duty  | 0  | 0  | 0  | 0  | 0  | 
Net Sales  | 1,569.4  | 1,465.7  | 1,239.69  | 1,258.51  | 1,138.09  | 
Other Operating Income  | 0  | 0  | 0  | 0  | 0  | 
Other Income  | 33.1  | 9.6  | 10.11  | 5.99  | 11.33  | 
Total Income  | 1,602.5  | 1,475.3  | 1,249.8  | 1,264.51  | 1,149.43  | 
Total Expenditure  | 1,184  | 1,068.2  | 937.1  | 924.2  | 823.68  | 
PBIDT  | 418.5  | 407.1  | 312.69  | 340.31  | 325.75  | 
Interest  | 52.5  | 37.8  | 28.76  | 18.24  | 16.94  | 
PBDT  | 366  | 369.3  | 283.93  | 322.07  | 308.81  | 
Depreciation  | 97.2  | 80  | 81.63  | 64.87  | 68.72  | 
Minority Interest Before NP  | 0  | 0  | 0  | 0  | 0  | 
Tax  | 70.7  | 78.8  | 47.15  | 69.05  | 57.92  | 
Deferred Tax  | -0.8  | -5.4  | 7.22  | 0.18  | 1.66  | 
Reported Profit After Tax  | 198.9  | 215.9  | 147.94  | 187.97  | 180.5  | 
Minority Interest After NP  | 8.4  | 21.9  | 10.77  | 15.13  | 11.25  | 
Net Profit after Minority Interest  | 190.5  | 194  | 137.17  | 172.83  | 169.25  | 
Extra-ordinary Items  | 10.8  | 0  | 0  | 0  | 0  | 
Adjusted Profit After Extra-ordinary item  | 179.7  | 194  | 137.17  | 172.83  | 169.25  | 
EPS (Unit Curr.)  | 4.76  | 4.85  | 17.15  | 21.6  | 21.15  | 
Book Value (Unit Curr.)  | 0  | 0  | 0  | 0  | 0  | 
Dividend (%)  | 0  | 0  | 0  | 0  | 0  | 
Equity  | 80  | 80  | 80  | 80.03  | 80.03  | 
Public Shareholding (Number)  | 0  | 0  | 0  | 0  | 0  | 
Public Shareholding (%)  | 0  | 0  | 0  | 0  | 0  | 
Pledged/Encumbered - No. of Shares  | 0  | 0  | 0  | 0  | 0  | 
Pledged/Encumbered - % in Total Promoters Holding  | 0  | 0  | 0  | 0  | 0  | 
Pledged/Encumbered - % in Total Equity  | 0  | 0  | 0  | 0  | 0  | 
Non Encumbered - No. of Shares  | 0  | 0  | 0  | 0  | 0  | 
Non Encumbered - % in Total Promoters Holding  | 0  | 0  | 0  | 0  | 0  | 
Non Encumbered - % in Total Equity  | 0  | 0  | 0  | 0  | 0  | 
PBIDTM(%)  | 26.66  | 27.77  | 25.22  | 27.04  | 28.62  | 
PBDTM(%)  | -  | -  | -  | -  | -  | 
PATM(%)  | 12.67  | 14.73  | 11.93  | 14.93  | 15.85  | 
Here are some of the stocks that may see significant price movement today: GIC Re, GSK Pharma, Godfrey Philips, etc.
It has entered into a share purchase agreement to acquire a 100% equity stake in Chalasani Hospitals Pvt Ltd.
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.